ImmPACT-Bio USA, Inc
ImmPACT-Bio USA, Inc., based in Camarillo, CA, is at the forefront of developing advanced cell therapies aimed at addressing significant medical needs, particularly in oncology and autoimmune diseases. Their innovative CAR T cell technologies are designed to prevent antigen escape, combat immunosuppressive environments, and selectively target cancer cells while sparing normal tissue.
Co-founded by pioneering scientists and in collaboration with leading research institutions, ImmPACT-Bio combines expertise with cutting-edge science to create next-generation therapies, including bispecific CAR T cells for conditions like Systemic Lupus Erythematosus and gastric cancer. In 2021, the company merged with Kalthera Therapeutics, further enhancing its capabilities in the field of immunotherapy.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.